Institut Català de la Salut
[Aterido A, López-Lasanta M, Palau N, Marsal S, Julià A] Grup de Recerca en Reumatologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Blanco F] Rheumatology Department, Hospital Juan Canalejo, A Coruña, Spain. [Juan Mas A] Rheumatology Department, Hospital Son Llatzer, Palma, Spain. [García Vivar ML] Rheumatology Department, Hospital Universitario Barsuto, Bilbao, Spain. [Erra A] Grup de Recerca en Reumatologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2024-03-18T13:48:30Z
2024-03-18T13:48:30Z
2024-03-11
Immune receptor; Rheumatoid arthritis; Phenotypes
Receptores inmunes; Artritis reumatoide; Fenotipos
Receptors immunitaris; Artritis reumatoide; Fenotips
Background In rheumatoid arthritis (RA), the activation of T and B cell clones specific for self-antigens leads to the chronic inflammation of the synovium. Here, we perform an in-depth quantitative analysis of the seven chains that comprise the adaptive immune receptor repertoire (AIRR) in RA. Results In comparison to controls, we show that RA patients have multiple and strong differences in the B cell receptor repertoire including reduced diversity as well as altered isotype, chain, and segment frequencies. We demonstrate that therapeutic tumor necrosis factor inhibition partially restores this alteration but find a profound difference in the underlying biochemical reactivities between responders and non-responders. Combining the AIRR with HLA typing, we identify the specific T cell receptor repertoire associated with disease risk variants. Integrating these features, we further develop a molecular classifier that shows the utility of the AIRR as a diagnostic tool. Conclusions Simultaneous sequencing of the seven chains of the human AIRR reveals novel features associated with the disease and clinically relevant phenotypes, including response to therapy. These findings show the unique potential of AIRR to address precision medicine in immune-related diseases.
This study was funded by Instituto de Salud Carlos III through the project PI17/00019 (Co-funded by European Regional Fund “A way to make Europe”) and by the Spanish Ministry of Economy and Competitiveness (grant number: IPT010000–2010–36). The study sponsors had no role in the collection, analysis, or interpretation of the data.
Article
Published version
English
Artritis reumatoide - Aspectes genètics; Fenotip; Factor de necrosi tumoral; Receptors cel·lulars; PHENOMENA AND PROCESSES::Genetic Phenomena::Phenotype; CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Monokines::Tumor Necrosis Factor-alpha; DISEASES::Immune System Diseases::Autoimmune Diseases::Arthritis, Rheumatoid; Other subheadings::Other subheadings::Other subheadings::/genetics; CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Immunologic; FENÓMENOS Y PROCESOS::fenómenos genéticos::fenotipo; COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::péptidos::péptidos y proteínas de señalización intercelular::citocinas::monocinas::factor de necrosis tumoral alfa; ENFERMEDADES::enfermedades del sistema inmune::enfermedades autoinmunes::artritis reumatoide; Otros calificadores::Otros calificadores::Otros calificadores::/genética; COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores inmunológicos
BMC
Genome Biology;25
https://doi.org/10.1186/s13059-024-03210-0
info:eu-repo/grantAgreement/ES/PE2017-2020/PI17%2F00019
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]